Literature DB >> 28558380

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.

Han Liu1, Bo Sun2, Shengnan Wang1, Congjin Liu1, Yun Lu1, Ding Li1, Xingdang Liu1.   

Abstract

BACKGROUND/AIMS: Circulating tumor cells (CTCs) are valuable in both basic research and clinical application for cancer management. In the current study, we evaluated the diagnostic value of CTCs in pancreatic ductal adenocarcinoma (PDAC).
METHODS: In total, 143 blood samples from 95 consecutively diagnosed PDAC patients and 48 healthy donors were collected. Combined data from immunostaining of CD45, DAPI and fluorescence in situ hybridization (FISH) with chromosome 8 centromere (CEP8) probe were used to identify CTCs. Cells with features of CD45-/DAPI+/CEP8>2 were detected as CTCs.
RESULTS: CTCs were classified as triploid, tetraploid and multiploid based on chromosome 8 copy number. CTC subtype composition was significantly different among groups. Both subtype number and total CTC number were significantly increased in PDAC patients, compared to healthy controls. Total CTC number had 75.8% sensitivity and 68.7% specificity at a cutoff value of 2 cells/3.2 mL. This study is the first to report that CTC subtype number is also useful in cancer diagnosis. Sensitivity was 53.7% and specificity was 85.4% at a cutoff point of 2 CTC subtypes. The diagnostic value of both total CTC number and CTC subtype number was a little poorer than CA199.
CONCLUSIONS: Both CTC subtype and total CTC number may serve as potential biomarkers for PDAC.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Aneuploidy; Biomarker; Circulating tumor cells; Pancreatic cancer

Mesh:

Substances:

Year:  2017        PMID: 28558380     DOI: 10.1159/000477481

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

Review 1.  Pancreatic cancer subtypes: a roadmap for precision medicine.

Authors:  Carolina Torres; Paul J Grippo
Journal:  Ann Med       Date:  2018-03-22       Impact factor: 4.709

2.  Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.

Authors:  Yuzhou Zhu; Hao Zhang; Nan Chen; Jianqi Hao; Hongyu Jin; Xuelei Ma
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

3.  Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.

Authors:  Seung Joon Lee; Tae Seok Sim; Hyun Young Shin; Jungmin Lee; Min Young Kim; Joseph Sunoo; Jeong-Gun Lee; Kyungmoo Yea; Young Zoon Kim; Danny van Noort; Soo Kyung Park; Woon-Hae Kim; Kyun Woo Park; Minseok S Kim
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

4.  Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.

Authors:  Hao Cheng; Wei He; Jun Yang; Qing Ye; Lu Cheng; Yiming Pan; Liang Mao; Xuehui Chu; Chenglin Lu; Gang Li; Yudong Qiu; Jian He
Journal:  Cell Prolif       Date:  2020-07-24       Impact factor: 6.831

5.  Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy.

Authors:  Tian-Bao Yan; Jia-Qi Huang; Shi-Yun Huang; Bhavesh K Ahir; Long-Man Li; Zeng-Nan Mo; Jian-Hong Zhong
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

6.  Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.

Authors:  Brittany Rupp; Sarah Owen; Harrison Ball; Kaylee Judith Smith; Valerie Gunchick; Evan T Keller; Vaibhav Sahai; Sunitha Nagrath
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

7.  ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells.

Authors:  Rossana Signorelli; Teresa Maidana Giret; Oliver Umland; Marco Hadisurya; Shweta Lavania; John Lalith Charles Richard; Ashley Middleton; Melinda Minucci Boone; Ayse Burcu Ergonul; Weiguo Andy Tao; Haleh Amirian; Anton Iliuk; Aliya Khan; Robert Diaz; Daniel Bilbao Cortes; Monica Garcia-Buitrago; Harrys Kishore Charles Jacob
Journal:  Biomedicines       Date:  2022-08-16

Review 8.  The Significance of Liquid Biopsy in Pancreatic Cancer.

Authors:  Zi-Hao Qi; Hua-Xiang Xu; Shi-Rong Zhang; Jin-Zhi Xu; Shuo Li; He-Li Gao; Wei Jin; Wen-Quan Wang; Chun-Tao Wu; Quan-Xing Ni; Xian-Jun Yu; Liang Liu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

Review 9.  Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

Authors:  Robert S O'Neill; Alina Stoita
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

10.  A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.

Authors:  Junliang Chen; Huaitao Wang; Lei Zhou; Zhihao Liu; Xiaodong Tan
Journal:  J Clin Lab Anal       Date:  2022-03-25       Impact factor: 3.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.